Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.20.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Class A Common Stock
Common stock
Class A Common Stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Retained earnings
Retained earnings
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 27, 2018       97,588,000        
Beginning balance at Dec. 27, 2018 $ 584,309 $ (179)   $ 98 $ 340,462 $ 186 $ 243,563 $ (179)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation expense 2,250       2,250      
Exercise of stock options (in shares)       348,000        
Exercise of stock options 1,776       1,776      
Shares issued under employee stock plans (in shares)       61,000        
Shares issued under employee stock plans 1,419       1,419      
Other comprehensive gain (loss), net of tax (334)         (334)    
Net income 30,720           30,720  
Ending balance (in shares) at Mar. 28, 2019       97,997,000        
Ending balance at Mar. 28, 2019 619,961     $ 98 345,907 (148) 274,104  
Beginning balance (in shares) at Dec. 27, 2018       97,588,000        
Beginning balance at Dec. 27, 2018 584,309 $ (179)   $ 98 340,462 186 243,563 $ (179)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Other comprehensive gain (loss), net of tax (547)              
Net income 115,290              
Ending balance (in shares) at Sep. 26, 2019       101,025,000        
Ending balance at Sep. 26, 2019 723,040     $ 101 364,626 (361) 358,674  
Beginning balance (in shares) at Mar. 28, 2019       97,997,000        
Beginning balance at Mar. 28, 2019 619,961     $ 98 345,907 (148) 274,104  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation expense 2,168       2,168      
Exercise of stock options (in shares)       1,090,000        
Exercise of stock options 5,376     $ 1 5,375      
Issuance of restricted stock awards (in shares)       24,000        
Issuance of restricted stock awards 0              
Other comprehensive gain (loss), net of tax (213)         (213)    
Net income 43,596           43,596  
Ending balance (in shares) at Jun. 27, 2019       99,111,000        
Ending balance at Jun. 27, 2019 670,888     $ 99 353,450 (361) 317,700  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation expense 2,242       2,242      
Exercise of stock options (in shares)       1,871,000        
Exercise of stock options 7,910     $ 2 7,908      
Shares issued under employee stock plans (in shares)       43,000        
Shares issued under employee stock plans 1,026       1,026      
Other comprehensive gain (loss), net of tax 0              
Net income 40,974           40,974  
Ending balance (in shares) at Sep. 26, 2019       101,025,000        
Ending balance at Sep. 26, 2019 723,040     $ 101 364,626 (361) 358,674  
Beginning balance (in shares) at Dec. 26, 2019     101,457,858 101,458,000        
Beginning balance at Dec. 26, 2019 764,336     $ 101 370,413 (193) 394,015  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation expense 2,908       2,908      
Exercise of stock options (in shares)       453,000        
Exercise of stock options 3,783     $ 1 3,782      
Issuance of restricted stock awards (in shares)       368,000        
Issuance of restricted stock awards 0              
Shares issued under employee stock plans (in shares)       30,000        
Shares issued under employee stock plans 1,131       1,131      
Other comprehensive gain (loss), net of tax 68         68    
Net income 37,063           37,063  
Ending balance (in shares) at Mar. 26, 2020       102,309,000        
Ending balance at Mar. 26, 2020 809,289     $ 102 378,234 (125) 431,078  
Beginning balance (in shares) at Dec. 26, 2019     101,457,858 101,458,000        
Beginning balance at Dec. 26, 2019 $ 764,336     $ 101 370,413 (193) 394,015  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Exercise of stock options (in shares) 2,027,087              
Other comprehensive gain (loss), net of tax $ 249              
Net income 137,841              
Ending balance (in shares) at Sep. 24, 2020     103,909,036 103,909,000        
Ending balance at Sep. 24, 2020 931,505     $ 104 399,489 56 531,856  
Beginning balance (in shares) at Mar. 26, 2020       102,309,000        
Beginning balance at Mar. 26, 2020 809,289     $ 102 378,234 (125) 431,078  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation expense 4,234       4,234      
Exercise of stock options (in shares)       838,000        
Exercise of stock options 4,877     $ 1 4,876      
Other comprehensive gain (loss), net of tax 92         92    
Net income 32,004           32,004  
Ending balance (in shares) at Jun. 25, 2020       103,147,000        
Ending balance at Jun. 25, 2020 850,496     $ 103 387,344 (33) 463,082  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation expense 4,400       4,400      
Exercise of stock options (in shares)       735,000        
Exercise of stock options 6,533     $ 1 6,532      
Shares issued under employee stock plans (in shares)       27,000        
Shares issued under employee stock plans 1,213       1,213      
Other comprehensive gain (loss), net of tax 89         89    
Net income 68,774           68,774  
Ending balance (in shares) at Sep. 24, 2020     103,909,036 103,909,000        
Ending balance at Sep. 24, 2020 $ 931,505     $ 104 $ 399,489 $ 56 $ 531,856